Results 241 to 250 of about 867,384 (315)
Objective Cardiovascular disease (CVD) is a leading cause of death in individuals with systemic lupus erythematosus (SLE). We assessed atherosclerotic plaque progression and incident cardiovascular events in patients with SLE over a 10‐year follow‐up.
Nikolaos Papazoglou+2 more
wiley +1 more source
Plasma endostatin at intensive care admission is independently associated with acute kidney injury, dialysis, and mortality in COVID-19. [PDF]
Koozi H+7 more
europepmc +1 more source
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim+5 more
wiley +1 more source
Efficient uremic toxins adsorption from simulated blood by immobilization of metal organic frameworks anchored Sephadex beads. [PDF]
Abdelhameed RM+3 more
europepmc +1 more source
Abstract Aims Phenoconversion, a genotype‐phenotype mismatch, challenges a successful implementation of personalized medicine. The aim of this study was to detect and determine phenoconversion using the solanidine metabolites 3,4‐seco‐solanidine‐3,4‐dioic acid (SSDA) and 4‐OH‐solanidine as diet‐derived cytochrome P450 2D6 (CYP2D6) biomarkers in a ...
Jens Andreas Sarömba+9 more
wiley +1 more source
Response to Response to Letter Regarding "An Artificial Neural Network-Based Model to Predict Chronic Kidney Disease in Aged Cats". [PDF]
Wun MK.
europepmc +1 more source
Abstract Aims The aim of this study was to determine if head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatin chemoradiotherapy and short hydration (SH) experience less dose‐limiting toxicity (DLT) and receive more cisplatin than those with medium hydration (MH) or long hydration (LH).
Anouk W. M. A. Schaeffers+10 more
wiley +1 more source
AKI in chronic myeloid leukemia: remember lysozyme-induced nephropathy. [PDF]
Santos A, Marques N, Pestana R.
europepmc +1 more source
Aims The aim of this phase 1 trial was to assess the pharmacokinetics, safety and tolerability of balcinrenone (previously AZD9977) in participants with severe renal impairment vs. those with normal renal function. Methods Participants with severe renal impairment (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m2) not on dialysis were ...
Chandrali S. Bhattacharya+10 more
wiley +1 more source
Fibrillary Glomerulonephritis: Clinicopathological Characteristics and Outcome-Case Series From a Multicentre Australasian Cohort. [PDF]
Komala MG+5 more
europepmc +1 more source